In the rapidly evolving healthcare landscape, personalized medicine and
nanotechnology spearhead transformative advancements. Personalized medicine
harnesses insights from genomic profiling and biomarker analysis to tailor treatments
precisely to individual genetic and physiological profiles, leveraging predictive
modelling and artificial intelligence for optimized therapeutic outcomes. This shift
from generalized treatments to personalized interventions holds promise for improving
efficacy and reducing adverse effects. Concurrently, nanotechnology revolutionizes
medical practices with its sophisticated tools for targeted drug delivery, precise
diagnostics, and real-time health monitoring through nanosensors and smart
nanomaterials. Future directions in personalized medicine include integrating multiomics data to refine patient profiling, thereby enhancing diagnostic accuracy and
therapeutic efficacy. Nanotechnology's impact spans across various medical domains,
enhancing cancer treatment through targeted drug delivery systems and advancing
cardiovascular care with nanoscale therapies for tissue repair and monitoring. It also
holds potential in neurodegenerative disorders, diabetes, genetic conditions,
autoimmune diseases, and respiratory disorders, enabling tailored treatments and early
disease detection through advanced imaging and sensing technologies. Genetic and
cellular interventions are pivotal, with CRISPR technology enabling precise gene
editing and nanocarriers facilitating targeted gene delivery for therapeutic applications.
The synergy of personalized medicine and nanotechnology promises to redefine
healthcare by offering customized treatments, improving patient outcomes, and
advancing proactive disease management strategies, although ethical considerations
and regulatory frameworks will shape their implementation and accessibility in clinical
practice.
Keywords: Applications, CRISPR-Cas9, Genetic interventions, Nanotechnology, Personalised treatments, Vaccines.
